Sun Pharma shares fell 5% after a 20% drop in Q1 profit and rising tariff concerns. Analyst Dhwani Patel noted a technical breakdown, with support around ₹1,560 and bearish momentum indicated by DMI. The stock slipped below key moving averages, turning retail sentiment 'bearish' on Stocktwits; it is down 14% YTD.